PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Apr-2020 Genalyte Expands Laboratory Services Offering with Acquisition of BaseHealth Genalyte
24-Apr-2020 Actinium Pharmaceuticals, Inc. Announces Closing of $31.6 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares Actinium Pharmaceuticals, Inc.
24-Apr-2020 FDA Provides Updates on Adverse Event Reports and Postmarket Activities Associated with Essure U.S. Food and Drug Administration
24-Apr-2020 Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for 'Off-Label' Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems U.S. Food and Drug Administration
24-Apr-2020 Medidata Accelerates Launch of myMedidata Platform, Responding to COVID-19 Medidata
24-Apr-2020 Flowchem firm joins fight against Coronavirus Flowchem
24-Apr-2020 FDA approves MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination Sanofi
24-Apr-2020 Almac Group increases volume of essential clinical supplies to patients in their homes Almac Group
24-Apr-2020 Pharnext and the University Hospital Institute Méditérranée Infection Announce a Joint Effort to Evaluate Repurposed Drugs for Potential Use Against the COVID-19 Virus Pharnext
24-Apr-2020 Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting Santhera Pharmaceuticals
24-Apr-2020 Cegedim Supporting Patient Care during COVID-19 Cegedim
24-Apr-2020 ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine ReiThera
24-Apr-2020 Biocomposites announces new CE Mark for STIMULAN® Optimum Strategic Communications
24-Apr-2020 Testing of anti-viral for treating COVID-19 underway Open Orphan plc
24-Apr-2020 EASE Study Enrollment Closed; Top Line Data Expected in Late Q3/Early Q4 2020 Amryt Pharma plc
24-Apr-2020 New commitment to SwanBio in Syncona’s largest Series A financing Syncona Ltd
24-Apr-2020 Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in relapsing multiple sclerosis Sanofi
24-Apr-2020 Sofinnova Partners co-led Series A Financing for Nitrome Biosciences Raising $38M Sofinnova Partners
24-Apr-2020 The UK looks to healthtech startups as coronavirus pandemic puts spotlight on fast-growing sector DCMS
24-Apr-2020 Northwest Laboratory Announces High Capacity Rapid Testing for COVID-19 Northwest Laboratory